Michael Loschi

25PUBLICATIONS
164CO-AUTHORS
Regenerative medicine (incl. stem cells)HaematologyCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Apr 16, 2026
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|Sep 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

Maxime Jullien, Eolia Brissot, Etienne Daguindau

|Sep 09, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.

Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard

Pageof 5

Frequent Collaborators

9 joint publications

Edouard Forcade

7 joint publications

Marie Robin

5 joint publications

Raynier Devillier

5 joint publications

Emmanuel Bachy